Lifecore Biomedical, Inc. De (LFCR) Total Non-Current Liabilities (2011 - 2025)

Lifecore Biomedical's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $166.9 million for Q2 2025.

• In Q2 2025, Total Non-Current Liabilities fell 11.21% year-over-year to $166.9 million; the TTM figure through May 2025 stood at $166.9 million (down 11.21% YoY), while the FY2025 annual figure was $166.9 million, down 11.21% from the prior year.
• Total Non-Current Liabilities was $166.9 million for Q2 2025 at Lifecore Biomedical, roughly flat from $166.4 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $301.6 million in Q1 2021 to a low of $153.6 million in Q2 2023.
• Historically, Total Non-Current Liabilities has averaged $198.9 million across 5 years, with a median of $184.9 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities slumped 39.95% in 2022, then grew 22.43% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $264.0 million in 2021, then fell by 22.47% to $204.6 million in 2022, then slipped by 22.07% to $159.5 million in 2023, then advanced by 19.44% to $190.5 million in 2024, then fell by 12.37% to $166.9 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $166.9 million (Q2 2025), $166.4 million (Q1 2025), and $190.5 million (Q4 2024), per Business Quant data.